Actualizar mis citas con la selección
Presentar
resultados
Douros A, Lix LM, Fralick M, Shah BR, Ronksley PE, Tremblay E, Hu N, Alessi-Severini S, Fisher A, Bugden SC, Ernst P, Filion KB, for the Canadian Network of Observational Drug Effect Studies (CNODES) Investigators.
Sodium–glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis A multicenter cohort study.
Ann Intern Med 2020:28 de julio. [Ref.ID 103685]
Pasternak B, Wintzell V, Melbye M, Eliasson B, Svensson A-M, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Svanström H, Ueda P.
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study.
BMJ 2020;369:29 de abril. [Ref.ID 103626]
Pasternak B, Ueda P, Eliasson B, Svensson A-M, Franzén S, Gudbjörnsdottir S, Hveern K, Jonasson C, Wintzell V, Melbye M, Svanström H.
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
BMJ 2019;366:29 de agosto. [Ref.ID 103243]
Actualizar mis citas con la selección